Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Surgery time interval and molecular subtype may influence Ki67 change after core needle biopsy in breast cancer patients
Authors
Keywords
Breast cancer, Core needle biopsy, Ki67 change, Molecular subtype, Surgery time interval
Journal
BMC CANCER
Volume 15, Issue 1, Pages -
Publisher
Springer Nature
Online
2015-10-30
DOI
10.1186/s12885-015-1853-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Clinical Impact of Delaying Initiation of Adjuvant Chemotherapy in Patients With Breast Cancer
- (2014) Debora de Melo Gagliato et al. JOURNAL OF CLINICAL ONCOLOGY
- Progesterone Receptor Status and Ki-67 Index May Predict Early Relapse in Luminal B/HER2 Negative Breast Cancer Patients: A Retrospective Study
- (2014) Yu Zong et al. PLoS One
- Association of molecular subtypes with Ki-67 changes in untreated breast cancer patients undergoing pre-surgical trials
- (2013) S. Gandini et al. ANNALS OF ONCOLOGY
- Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) E. Senkus et al. ANNALS OF ONCOLOGY
- Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
- (2013) A. Goldhirsch et al. ANNALS OF ONCOLOGY
- Preoperative core needle biopsy is accurate in determining molecular subtypes in invasive breast cancer
- (2013) Xiaosong Chen et al. BMC CANCER
- Selecting the neoadjuvant treatment by molecular subtype: How to maximize the benefit?
- (2013) Gunter von Minckwitz et al. BREAST
- Ki67 Measured after Neoadjuvant Chemotherapy for Primary Breast Cancer
- (2013) G. von Minckwitz et al. CLINICAL CANCER RESEARCH
- Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
- (2013) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer
- (2012) Karin Milde-Langosch et al. BREAST CANCER RESEARCH AND TREATMENT
- Accuracy of estrogen receptor, progesterone receptor, and HER2 status between core needle and open excision biopsy in breast cancer: a meta-analysis
- (2012) Xiaosong Chen et al. BREAST CANCER RESEARCH AND TREATMENT
- Dual Effect of Metformin on Breast Cancer Proliferation in a Randomized Presurgical Trial
- (2012) Bernardo Bonanni et al. JOURNAL OF CLINICAL ONCOLOGY
- Does Breast Tumor Heterogeneity Necessitate Further Immunohistochemical Staining on Surgical Specimens?
- (2012) Lauren T. Greer et al. JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS
- Percutaneous Needle vs Surgical Breast Biopsy: Previous Allegations of Overuse of Surgery Are in Error
- (2012) David C. Levin et al. Journal of the American College of Radiology
- Ki67 Index, HER2 Status, and Prognosis of Patients With Luminal B Breast Cancer
- (2009) Maggie C. U. Cheang et al. JNCI-Journal of the National Cancer Institute
- Research Issues Affecting Preoperative Systemic Therapy for Operable Breast Cancer
- (2008) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started